On January 19, 2018, Castle Biosciences Incorporated closed the transaction. The transaction included participation from 48 investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.23 USD | -1.49% |
|
+9.95% | -10.94% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.94% | 54Cr | |
-6.61% | 1.21TCr | |
+92.85% | 819.97Cr | |
-18.38% | 658.64Cr | |
+9.13% | 588.57Cr | |
-21.66% | 347.09Cr | |
+5.36% | 252.41Cr | |
+42.89% | 247.9Cr | |
+17.72% | 230.26Cr | |
-18.43% | 157.6Cr |
- Stock Market
- Equities
- CSTL Stock
- News Castle Biosciences, Inc.
- Castle Biosciences Incorporated announced that it has received $5.48 million in funding